Rosemary Chester

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.

Stephen R. Wedge, Donald Ogilvie, Michael Dukes et al. · PubMed · 2002 · 802 citations

Oral Administration, Pharmacotherapy, Tumor Biology +18

AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer

Stephen R. Wedge, Jane Kendrew, Laurent Hennequin et al. · Cancer Research · 2005 · 706 citations · Full text

Delay of Parturition in the Rat by Anti-Inflammatory Agents which Inhibit the Biosynthesis of Prostaglandins

Rosemary Chester, M. Dukes, S. R. Slater et al. · Nature · 1972 · 136 citations

Inflammation, Anti-inflammatory, Anti-inflammatory Agents +6

The association between ethnicity, socioeconomic deprivation and receipt of hospital-based palliative care for people with Covid-19: A dual centre service evaluation

Sabrina Bajwah, Polly Edmonds, Emel Yorganci et al. · Palliative Medicine · 2021 · 16 citations · Full text

Heart failure—the experience of living with end-stage heart failure and accessing care across settings

Rosemary Chester, Heather Richardson, Christopher Doyle et al. · Annals of Palliative Medicine · 2021 · 14 citations · Full text